Low‐Dose Clonidine Enhances Pregnancy‐Induced Analgesia to Visceral but Not Somatic Stimuli in Rats

H. Iwasaki,J. G. Collins,Y. Saito,H. Uchida,Ann Kerman-hinds

DOI: https://doi.org/10.1213/00000539-199002001-00171

1991-03-01

Abstract:This is one of a series of experiments designed to examine the possible pharmacologic basis for analgesia normally associated with pregnancy. The antinociceptive effects of low-dose (0.1 mg/kg) subcutaneous clonidine on analgesia associated with pregnancy were evaluated in rats. Colorectal distention thresholds and tail-pick latencies were determined in timed pregnant rats (n = 27) before mating, On days and 21 Of gestation, and On postpartum day 7. Immediately after baseline testing on each of those days, animals received 0.1 mg/kg clonidine subcutaneously and were retested 30 min later. On day 21 of gestation, 20 μg/kg naloxone (n = 9) and 0.2 mg/kg yohimbine (n = 5) were intravenously administered after clonidine testing, and animals were retested 15 min later.In the absence of clonidine, pregnant animals demonstrated a statistically significant increase in their tolerance of colorectal distention pressures and longer latencies to tail-flick withdrawal on day 21 of gestation. Clonidine produced a further significant increase in distention thresholds on day 21 of gestation but did not change these thresholds on any other day, nor did it change tail‐flick latencies. Naloxone and yohimbine reversed the effect of clonidine on the distention thresholds on day 21.Systemic clonidine, at a dose lower than that required to produce antinociception in nonpregnant rats, enhanced pregnancy‐induced analgesia to visceral stimulation late in pregnancy, an effect that was reversed by naloxone and yohimbine. These results suggest a synergistic antinociceptive days, of clonidine due to an interaction with an endogenous opiate system that is only activated late in Pregnancy.